Evaluation of artificial intelligence identified ipratropium bromide for the treatment of coronavirus disease 2019. [PDF]
Jung DS +11 more
europepmc +1 more source
Development of a stable replicon system of a pangolin merbecovirus for antiviral screening. [PDF]
Wu CG, Wang JH, Zhu B, Chen J.
europepmc +1 more source
Medication errors and associated serious outcomes in COVID-19 antivirals: a real-world study based on FDA Adverse Event Reporting System database. [PDF]
Xiong X, Chen Z, Yan B.
europepmc +1 more source
Remdesivir safety and clinical outcomes in pediatric COVID-19: a retrospective study. [PDF]
Barati L +3 more
europepmc +1 more source
Remdesivir may exacerbate ischemic acute kidney injury through molecular alterations in PGC-1α and apoptosis pathways: An in vivo study. [PDF]
Bagheri Y +8 more
europepmc +1 more source
Remdesivir as a potent antiviral against prototype and current epidemic Oropouche virus strains (BeAn19991 and PE-IAM4637). [PDF]
Yoshikawa R, Ishii Y, Sano N, Yasuda J.
europepmc +1 more source
Repurposing of FDA-Approved Antiviral Drugs Against Monkeypox Virus: Comparative In Vitro Screening and Structure Based In Silico Studies. [PDF]
Moatasim Y +9 more
europepmc +1 more source
Combination Therapy With Ensitrelvir and Remdesivir Versus Antiviral Monotherapy in Patients Receiving Anti-CD20 Monoclonal Antibody Therapy: A Retrospective Cohort Study. [PDF]
Takano T +3 more
europepmc +1 more source
Role of Treatment with Remdesivir on the Early Readmission of Patients Affected by Nosocomial Coronavirus Disease 2019. [PDF]
Boglione L +6 more
europepmc +1 more source

